key: cord-1046324-s9l6jx7b
authors: Sapienza, Lucas G.; Nasra, Karim; Calsavara, Vinícius F.; Little, Tania B.; Narayana, Vrinda; Abu-Isa, Eyad
title: Risk of in-hospital death associated with Covid-19 lung consolidations on chest computed tomography – A novel translational approach using a radiation oncology contour software()
date: 2021-01-06
journal: Eur J Radiol Open
DOI: 10.1016/j.ejro.2021.100322
sha: 197864c0f8cb98d8edacb0595625238c84aed6ec
doc_id: 1046324
cord_uid: s9l6jx7b

PURPOSE: To determine whether the percentage of lung involvement at the initial chest computed tomography (CT) is related to the subsequent risk of in-hospital death in patients with coronavirus disease-2019 (Covid-19). MATERIALS AND METHODS: Using a cohort of 154 laboratory-confirmed Covid-19 pneumonia cases that underwent chest CT between February and April 2020, we performed a volumetric analysis of the lung opacities. The impact of relative lung involvement on outcomes was evaluated using multivariate logistic regression. The primary endpoint was the in-hospital mortality rate. The secondary endpoint was major adverse hospitalization events (intensive care unit admission, use of mechanical ventilation, or death). RESULTS: The median age of the patients was 65 years: 50.6 % were male, and 36.4 % had a history of smoking. The median relative lung involvement was 28.8 % (interquartile range 9.5–50.3). The overall in-hospital mortality rate was 16.2 %. Thirty-six (26.3 %) patients were intubated. After adjusting for significant clinical factors, there was a 3.6 % increase in the chance of in-hospital mortality (OR 1.036; 95 % confidence interval, 1.010–1.063; P = 0.007) and a 2.5 % increase in major adverse hospital events (OR 1.025; 95 % confidence interval, 1.009–1.042; P = 0.002) per percentage unit of lung involvement. Advanced age (P = 0.013), DNR/DNI status at admission (P < 0.001) and smoking (P = 0.008) also increased in-hospital mortality. Older (P = 0.032) and male patients (P = 0.026) had an increased probability of major adverse hospitalization events. CONCLUSIONS: Among patients hospitalized with Covid-19, more lung consolidation on chest CT increases the risk of in-hospital death, independently of confounding clinical factors.

infection are commonly visualized on radiological exams as groundglass and diffuse patchy opacities [1] [2] [3] . Due to superior spatial resolution, these changes are usually better visualized by chest computed tomography (CT) instead of simple radiography [4, 5] .

Previous studies have indicated that imaging findings provide relevant information to establish diagnosis of coronavirus disease-2019 ( at multiple stages of the disease [ [6] [7] [8] [9] . Subsequent reports suggested a qualitative association between diffuse lung involvement and worse clinical outcomes [ [10] [11] [12] , but the magnitude of the increase in the probability given any amount of lung infiltrates at admission is still to be determined.

It is postulated that the reduction in the amount of gas exchange in the consolidation areas, as a result of the combined effect of viral infection and host defense [13] , plays a central role in the physiopathology of the . In this setting, we hypothesize that by proportionally reflecting lung parenchyma impairment, the quantity of opacities relative to the total lung volume may be used to predict the need for more intensive medical care and survival. We therefore conducted a study relating the percentage of lung involvement by consolidations at the initial CT to the subsequent risk of adverse clinical outcomes.

We screened all consecutive chest CT scans performed between February 1 st , 2020, and April 17 th , 2020, at two campuses of Michigan State University (Ascension Providence Southfield and Novi, MI, US). Cases with symptoms of viral pneumonia and confirmed by reverse transcription polymerase chain reaction (RT-PCR) for SARS-CoV-2 from nasopharynx swabs were retrospectively selected. Patients who had their first CTs performed after intensive care unit (ICU) admission or intubation (n = 21) were excluded.

Finally, four patients transferred to other institutions were excluded (eFigure 1 in the Supplementary Appendix). The present study was approved by the Ascension Providence Hospital Institutional Review Board (IRB number 1596627-1). Only retrospective deidentified information was used, and informed consent was waived.

CT PROTOCOL AND VOLUMETRIC DATA Nonenhanced chest CT scans from the lung apex to the bilateral costophrenic angles were performed in the feet-first and supine positions, using a 64-slice scanner (GE LightSpeed Volume CT, General Electric Healthcare, Chicago, Illinois, US). The breathing-hold technique was used. The acquisition was executed with 120 kV (tube voltage) and ~750 mA (Smart mA; tube current), and the image data sets were reconstructed with 1.25-mm slice thickness. There were no specific institutional recommendations regarding the indication for chest CT.

After the case selection stage, the images of the initial CT were transferred from the radiology picture archiving and communication system (PACS) to the radiotherapy treatment planning software (Eclipse Treatment Planning System -Version 15.6; Varian Medical Systems, Palo Alto, CA, US). We choose radiation oncology software due to the J o u r n a l P r e -p r o o f enhanced structure delineation capability in three planes (axial, coronal and sagittal), realtime tridimensional reconstruction, and the precision of the volumetric measurement tools. The structure contours (consolidations and lungs) for all cases were performed independently by two radiation oncologists with 5 years and 10 years of experience and familiarity with the contour interface who were blinded to the clinical endpoints.

Discordances on final contours were resolved by consensus. The consolidations were analyzed and contoured using the lung window (-1000 to 0 Hounsfield units). Cases with massive peripheral opacities required alternating to the soft tissue window (-125 to 225 Hounsfield units) for better delineation of the lung-chest wall interface. Areas of emphysema and pleural effusion were not included in the normal lung and consolidation contours, respectively. The relative consolidation volume was calculated by dividing the volume of the lung consolidations measured in cubic centimeters by the total bilateral lung volume measured in cubic centimeters (eTable 1 in the Supplementary Appendix).

The primary endpoint was the in-hospital mortality rate. The secondary composite endpoint was major adverse hospitalization events, defined as admission to the ICU, use Qualitative variables are presented as absolute and relative frequencies.

Quantitative variables are presented as medians and interquartile ranges (IQRs). The previous coexisting diseases analyzed were hypertension, diabetes mellitus, dyslipidemia, chronic obstructive pulmonary disease, asthma/bronchitis, obstructive sleep apnea, coronary artery disease, stroke/transient ischemic attack, chronic kidney disease, cancer, acquired immunodeficiency syndrome, hepatitis B/C, and tuberculosis.

Initially, the possible association between the independent and dependent (outcomes) variables was quantified using the odds ratio estimated by a simple logistic regression model ( Table 1 

One hundred fifty-four patients with laboratory-confirmed diagnoses of SARS-CoV-2 infection who underwent chest CT met the study inclusion criteria. The male-tofemale ratio was 1:1. The median age of the patients was 65 years (interquartile range, 53 to 74), and the median body mass index was 31.1 kg/m 2 (interquartile range, 26.9 to 35.7). One-third of the patients had a history of smoking or were currently smoking. The median number of comorbidities was 3 (interquartile range, 1 to 4). Seventeen patients (11.0%) had DNR/DNI status at admission. Other patient characteristics are presented in the Table 1 Overall, the median hospitalization length from admission was 9 days (interquartile range, 5 to 14). During the hospital stay, forty-five (32.8%) required treatment at the ICU, and thirty-six (26.3%) were intubated to receive mechanical ventilation. The median ICU length was 9 days (interquartile range, 5.5 to 15.5). Twenty-five patients died, resulting in an overall in-hospital mortality rate of 16.2%. The in-hospital mortality rate was 28.9% for the patients admitted to the ICU and 36.1% if mechanical ventilation was used ( Table 2) . Table 3) . Each unit of percent increase in lung consolidation increased the chance of in-hospital death by 3.6% (OR 1.036; 95% confidence interval, 1.010 to 1.063; P=0.007). Figure 1 presents the probability of in-hospital death for four subgroups of full-code patients (older than 65 years of age with and without a smoking history, and younger than 65 years of age with and without a smoking history).

The quantity of lung consolidations relative to the lung volume was also independently associated with major adverse hospitalization events (P=0.002), with an increase of 2.5% (OR 1.025; 95% confidence interval, 1.009 to 1.042; P=0.002) in the chance per additional unit of percent lung involvement ( Table 3) . Other factors associated with an increased risk of major adverse hospital events were advanced age (P=0.032) and male sex (P=0.026). 

Since the initial case in January 2020 [14] , more than 18 million individuals have been diagnosed with in the United States [15] . There have been over three hundred thirty thousand deaths, and a higher number of individuals have developed J o u r n a l P r e -p r o o f severe disease, requiring escalated medical care involving hospitalization, admission to the ICU, and the use of mechanical ventilation. During the peak phase of the pandemic in the state of Michigan (March-April 2020) [15] , medical resources were used towards the maximum, raising the problem of resource allocation in situations of mass critical care demand [16 -18] . In this scenario, tools to predict outcomes would be important to better triage patients who require more intensive support. On the other hand, patients who had a limited risk of developing major adverse events could be managed in a lower complexity facility or from home.

The present study indicated a quantitative increase in mortality and major adverse hospital events with more lung consolidations detected by CT in the setting of SARS-CoV-2 pneumonia. Each unit of percentage increase in lung involvement with consolidations increased the chance of in-hospital mortality by 3.6% and the chance of major adverse hospital events by 2.5%. Important information to better predict prognosis and guide clinical management can be derived from our findings. For example, a patient who is more than 65 years of age and has a history of smoking has a 15% risk of dying during hospitalization if 10% of the lung is involved at the initial assessment. That risk would escalate to 50% for a similar patient with 60% of lung involvement.

The clinical outcomes observed in our cohort were in line with experiences from other geographical areas. Eighty percent (36/45) of the cases admitted to the ICU in our series required mechanical ventilation, similar to the experiences from Seattle (US; 75%, 18/24) [1], Lombardy (Italy; 88%, 1150/1300) [19] , and Wuhan (China; 64%, 32/50) [20] .

The ICU mortality in the present study (28.6%,13/45) was also at the level found in the Italian data (26%, 405/1581) [19] but lower than Seattle's experience (50%, 12/24) [1] .

The increased ICU mortality described in Seattle's case series could be related to more severe presentations, including patients with a higher percentage of lungs with opacities and late-stage disease (quantitative data were not provided by the authors). In addition, Seattle's surge occurred before the peak in Michigan's cases, which could explain differences in management, including the use of systemic corticoid (none versus 97.8% on the ICU patients in our series) [21, 22] .

Of note, patients with do-not-resuscitate and do-not-intubate status at admission had twenty times higher chance of in-hospital mortality. It is unclear whether proceeding with mechanical ventilation or resuscitation maneuvers in those patients with low functional reserve would provide greater survival probability. In relation to cardiopulmonary resuscitation (CPR), previous experiences showed that less than 5% of patients survived CPR after a cardiac arrest event [23, 24] . Regarding mechanical ventilation, in the present study, two-thirds of the non-DNR/DNI (full-code) patients who required intubation recovered from respiratory insufficiency and were able to obtain a successful extubation.

Pleural effusions occurred in only 4% of the patients and were not associated to either endpoint. Other groups also reported a low incidence of pleural effusions [2, 3] , which could be related to exacerbation of other comorbidities instead of SARS- pneumonia. The other radiologic parameters, including absolute quantity of consolidations and the volume of nonaffected lung, were not used concomitantly as independent variables in the models due to their intrinsic relation with the percentage of lung involvement. Notwithstanding, a group from Piacenza (Italy) [19] indicated that cases J o u r n a l P r e -p r o o f with less well-aerated lung parenchyma on admission chest CT (< 73% vs. >/=73%), per visual and software assessments, were associated with increased ICU use or death.

Our study limitations include the effect of changes in the total lung volume during respiratory cycle, which could interfere with the denominator of the percent lung involvement calculation. This source of uncertainty was partially controlled by instructing the patient to hold his or her breath during the CT scan acquisition, which also reduced the artifacts in the area of the lung-diaphragm interface. Further maneuvers such as sustained maximum inspiration would not be possible for dyspneic patients. In addition, alternative models incorporating the absolute consolidation volume as the independent variable confirmed our results (data not shown). Importantly, the model for in-hospital mortality was more accurate in predicting the death event when compared with the model for major adverse hospitalization events (eFig S2AB), and both would benefit from external validation to minimize over-fitting bias. Another important limitation is the complexity of the infiltrate contour, which requires trained physicians and significant dedicated time. To illustrate this, videos of the contoured chest CTs of two cases are available online (Video 1 and Video 2). The first presented with 0.2% relative lung involvement that was contoured in less than ten minutes, and the second presented with 44.9% relative lung involvement that required three hours to be completed. Further studies creating and validating artificial intelligence systems using neural network algorithms [ [26] [27] [28] [29] could facilitate large scale quantification of percentage lung parenchyma compromised.

There is a quantitative relationship between lung involvement with consolidations and clinical outcomes. Per unit percent of lung involved, there was a 3.6% increase in the chance of in-hospital mortality and a 2.5% increase in major adverse hospital events. Therefore, this study provides evidence that chest CT is an potential tool in guiding escalation or de-escalation 

Review Board (IRB number 1596627-1). Only retrospective deidentified information was used, and informed consent was waived.

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. J o u r n a l P r e -p r o o f # odds ratio not estimated. § Median relative normal lung volume = volume of normal lung in cubic centimeters divided by the total bilateral lung volume in cubic centimeters. † Median relative lung consolidations volume = volume of the lung consolidations in cubic centimeters divided by the total bilateral lung volume in cubic centimeters.

Covid-19 in critically ill patients in the Seattle region -Case series

Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State

Coronavirus disease 2019 (COVID-19) CT findings: a systematic review and meta-analysis

Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study

Clinical characteristics of coronavirus disease 2019 in China

Correlation of chest CT and RT-PCR testing for coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases

Efficacy of chest CT for COVID-19 pneumonia in France

The use of simulation-CT's as a coronavirus disease 2019 screening tool during the severe acute respiratory syndrome coronavirus 2 pandemic

Coronavirus disease 2019: initial chest CT findings

COVID-19 pneumonia: diagnostic and prognostic role of CT based on a retrospective analysis of 214 consecutive patients from

The trinity of COVID-19: immunity, inflammation and intervention

First case of 2019 novel coronavirus in the United States

Triage of scarce critical care resources in COVID-19 An implementation guide for regional allocation: an expert panel report of the Task Force for Mass Critical Care and the American College of Chest Physicians

Ethical criteria for the admission and management of patients in the ICU under conditions of limited medical resources: a shared international proposal in view of the COVID-19 pandemic

Prioritisation of ICU treatments for critically ill patients in a COVID-19 pandemic with scarce resources

Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Dexamethasone in Hospitalized Patients with Covid-19 -Preliminary Report

Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis

In-hospital cardiac arrest outcomes among patients with COVID-19 pneumonia in Wuhan

Clinical outcomes of in-hospital cardiac arrest in COVID-19

Well-aerated lung on admitting chest CT to predict adverse outcome in COVID-19 pneumonia

Estimated Probability of in-hospital death: 14.3%. Estimated probability of major adverse hospital events: 22

Estimated Probability of in-hospital death: 25.6%. Estimated probability of major adverse hospital events: 46

Estimated Probability of in-hospital death: 5.4%. Estimated probability of major adverse hospital events: 32

Estimated Probability of in-hospital death: 29.5%. Estimated probability of major adverse hospital events: 80.2%. In-hospital death after 47 days (32 days in the ICU, 31 days of mechanical ventilation)

Receiver Operating Characteristics (ROC) Curves

Primary outcome: Nagelkerke's R 2 : 0.524

B) Secondary (composite) outcome: Nagelkerke's R 2 : 0.189

Acknowledgments: We thank Jeffrey Flynn Ph.D. and Maria Gomes M.D., M.Sc. for the assistance with the study design. We also thank Howard Schubiner M.D. from the

Admission to discharge (all) -median (IQR) -days 9.0 ( [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] Admission to discharge (survivors) -median (IQR)days 8 ( [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] Admission to CT -median (IQR) -days 0.0 (0-1)CT to discharge (all) -median (IQR) -days 8.0 ( [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] CT to discharge (survivors) -median (IQR) -days 7 (4. [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] ICU